{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:27:36Z","timestamp":1785526056923,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,15]],"date-time":"2013-12-15T00:00:00Z","timestamp":1387065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s11882-013-0409-1","type":"journal-article","created":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T05:23:30Z","timestamp":1386998610000},"source":"Crossref","is-referenced-by-count":71,"title":["Noninfectious Immune-Mediated Uveitis and Ocular Inflammation"],"prefix":"10.1007","volume":"14","author":[{"given":"Jennifer","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuj","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,15]]},"reference":[{"key":"409_CR1","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.ophtha.2011.07.027","volume":"118","author":"JH Kempen","year":"2011","unstructured":"Kempen JH, Altaweel MM, Holbrook JT, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the Multicenter Uveitis Steroid Treatment (MUST) Trial. Ophthalmology. 2011;118:1916\u201326.","journal-title":"Ophthalmology"},{"key":"409_CR2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332\u20136.","journal-title":"Br J Ophthalmol"},{"key":"409_CR3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","volume":"50","author":"JH Chang","year":"2005","unstructured":"Chang JH, McCluskey PJ, Fracs F, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50:364\u201388.","journal-title":"Surv Ophthalmol"},{"key":"409_CR4","first-page":"509","volume":"150","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature (SUN) for reporting clinical data. -Results of the First International Workshop. Am J Ophthalmol. 2005;150:509\u201316.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"409_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9394(14)76733-9","volume":"112","author":"LP D\u2019Alessandro","year":"1991","unstructured":"D\u2019Alessandro LP, Forster DJ, Rao NA. Anterior uveitis and hypopyon. Am J Ophthalmol. 1991;112(3):317\u201321.","journal-title":"Am J Ophthalmol"},{"key":"409_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archopht.1997.01100150063010","volume":"115","author":"JL Lyons","year":"1997","unstructured":"Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol. 1997;115:61.","journal-title":"Arch Ophthalmol"},{"key":"409_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.59.1.67","volume":"59","author":"ES Paiva","year":"2000","unstructured":"Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT. Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis. 2000;59:67.","journal-title":"Ann Rheum Dis"},{"key":"409_CR8","first-page":"561","volume":"11","author":"H Bayen","year":"1988","unstructured":"Bayen H, Bayen MC, De Curzon HP, et al. Involvement of the posterior eye segment in HLA B27 (+) iridocyclitis. J Fr Ophthalmol. 1988;11:561\u20136.","journal-title":"J Fr Ophthalmol"},{"issue":"1","key":"409_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15\u201325.","journal-title":"Arthritis Rheum"},{"key":"409_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/adc.61.2.168","volume":"61","author":"AM Leak","year":"1986","unstructured":"Leak AM, Ansell BM, Burman SJ. Antinuclear antibody studies in juvenile chronic arthritis. Arch Dis Child. 1986;61:168\u201372.","journal-title":"Arch Dis Child"},{"issue":"5","key":"409_CR11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0039-6257(03)00084-5","volume":"48","author":"K Kotaniemi","year":"2003","unstructured":"Kotaniemi K, Savolainen A, Karma A, Aho K. Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol. 2003;48(5):489\u2013502.","journal-title":"Surv Ophthalmol"},{"key":"409_CR12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2012.07.052","volume":"120","author":"AC Gregory 2nd","year":"2013","unstructured":"Gregory 2nd AC, Kempen JH, Daniel E, Kacmaz RO, Foster CS, et al. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology. 2013;120:186\u201392.","journal-title":"Ophthalmology"},{"key":"409_CR13","doi-asserted-by":"crossref","unstructured":"Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics. 2006; 117(5):1843\u20131845.","DOI":"10.1542\/peds.2006-0421"},{"key":"409_CR14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/rheumatology\/31.9.633","volume":"31","author":"TR Southward","year":"1992","unstructured":"Southward TR, Ryder CA. Ophthalmological screening in juvenile arthritis: should the frequency of screening be based on the risk of developing chronic iridocyclitis? Br J Rheumatol. 1992;31:633\u20134.","journal-title":"Br J Rheumatol"},{"key":"409_CR15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0002-9394(14)74327-2","volume":"103","author":"DE Henderly","year":"1987","unstructured":"Henderly DE, Haymond RS, Rao NA, Smith RE. The significance of the pars plana exudates in pars planitis. Am J Ophthalmol. 1987;103:669\u201371.","journal-title":"Am J Ophthalmol"},{"key":"409_CR16","first-page":"35","volume":"23","author":"JI David","year":"1992","unstructured":"David JI, Mittal KK, Nussenblatt RB. HLA in intermediate uveitis. Dev Ophthalmol. 1992;23:35\u20137.","journal-title":"Dev Ophthalmol"},{"key":"409_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09273940490895344","volume":"12","author":"G Zein","year":"2004","unstructured":"Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004;12:137.","journal-title":"Ocul Immunol Inflamm"},{"key":"409_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1076\/ocii.9.2.93.3975","volume":"9","author":"JF Prieto","year":"2001","unstructured":"Prieto JF, Dios E, Gutierrez JM, et al. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm. 2001;9:93.","journal-title":"Ocul Immunol Inflamm"},{"key":"409_CR19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0002-9394(78)90184-8","volume":"86","author":"CD Obenauf","year":"1978","unstructured":"Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86:648.","journal-title":"Am J Ophthalmol"},{"key":"409_CR20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1749-6632.1986.tb18532.x","volume":"465","author":"DG James","year":"1986","unstructured":"James DG. Ocular sarcoidosis. Ann N Y Acad Sci. 1986;465:551.","journal-title":"Ann N Y Acad Sci"},{"key":"409_CR21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9394(86)90001-2","volume":"102","author":"DA Jabs","year":"1986","unstructured":"Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986;102:297\u2013301.","journal-title":"Am J Ophthalmol"},{"key":"409_CR22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/clim.2000.4901","volume":"96","author":"S Hegab","year":"2000","unstructured":"Hegab S, Al-Mutawa S. Immunopathogenesis of Behcet\u2019s disease. Clin Immunol. 2000;96:174\u201386.","journal-title":"Clin Immunol"},{"key":"409_CR23","unstructured":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease. Lancet 1990;335:1078."},{"key":"409_CR24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archopht.1970.00990040453009","volume":"84","author":"JG Mamo","year":"1970","unstructured":"Mamo JG. The rate of visual loss in Beh\u00e7et's disease. Arch Ophthalmol. 1970;84:451.","journal-title":"Arch Ophthalmol"},{"key":"409_CR25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02169409","volume":"227","author":"LS Atmaca","year":"1989","unstructured":"Atmaca LS. Fundus changes associated with Beh\u00e7et's disease. Graefe's Arch Clin Exp Ophthalmol. 1989;227:340\u20134.","journal-title":"Graefe's Arch Clin Exp Ophthalmol."},{"key":"409_CR26","first-page":"278","volume":"19","author":"K Masuda","year":"1974","unstructured":"Masuda K, Inaba G, Mizushima II. A nationwide survey of Behcet\u2019s disease in Japan. Jpn J Ophthalmol. 1974;19:278\u201385.","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"409_CR27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archophthalmol.2011.2698","volume":"130","author":"AA Okada","year":"2012","unstructured":"Okada AA, Goto H, Ohno S, Mochizuki M, Ocular Beh\u00e7et's Disease Research Group Of Japan. Multicenter study of infliximab for refractory uveoretinitis in Beh\u00e7et disease. Arch Ophthalmol. 2012;130(5):592\u20138.","journal-title":"Arch Ophthalmol"},{"key":"409_CR28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archopht.1991.01080050096037","volume":"109","author":"PE Rubsamen","year":"1991","unstructured":"Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991;109:682.","journal-title":"Arch Ophthalmol"},{"key":"409_CR29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9394(14)74731-2","volume":"113","author":"XY Zhang","year":"1992","unstructured":"Zhang XY, Wang XM, Hu TS. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1992;113:567.","journal-title":"Am J Ophthalmol"},{"key":"409_CR30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9394(14)75078-0","volume":"90","author":"DA Snyder","year":"1980","unstructured":"Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1980;90:69\u201375.","journal-title":"Am J Ophthalmol"},{"key":"409_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","volume":"39","author":"RS Moorthy","year":"1995","unstructured":"Moorthy RS, Inomata H, Rao NAL. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265\u201392.","journal-title":"Surv Ophthalmol"},{"key":"409_CR32","first-page":"558","volume-title":"Sympathetic ophthalmitis, in Duke-Elder S: Diseases of the uveal tract","author":"S Duke-Elder","year":"1966","unstructured":"Duke-Elder S, Perkins ES. Sympathetic ophthalmitis, in Duke-Elder S: Diseases of the uveal tract. Mosby: St Louis; 1966. p. 558\u201393."},{"key":"409_CR33","first-page":"8.10","volume-title":"The uvea uveitis and intraocular neoplasms","author":"NA Rao","year":"1995","unstructured":"Rao NA, Forster DJ, Spalton DJ. Sympathetic ophthalmia. In: Podos SM, Yanoff M, editors. The uvea uveitis and intraocular neoplasms, vol. 2. USA: Mosby-Wolfe; 1995. p. 8.10\u20133. Chapter 8."},{"key":"409_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bjo.84.3.259","volume":"84","author":"DJ Kilmartin","year":"2000","unstructured":"Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000;84:259\u201363.","journal-title":"Br J Ophthalmol"},{"key":"409_CR35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-9394(84)90243-5","volume":"98","author":"RC Watzke","year":"1984","unstructured":"Watzke RC, Packer AJ, Folk JC, et al. Punctate inner choroidopathy. Am J Ophthalmol. 1984;98:572\u201384.","journal-title":"Am J Ophthalmol"},{"key":"409_CR36","first-page":"1645","volume":"11","author":"TF Schlaegel Jr","year":"1979","unstructured":"Schlaegel Jr TF. Eye histoplasmosis. Ann Ophthalmol. 1979;11:1645\u201354.","journal-title":"Ann Ophthalmol"},{"key":"409_CR37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archopht.1968.00980050179005","volume":"80","author":"JD Gass","year":"1968","unstructured":"Gass JD. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1968;80:177\u201385.","journal-title":"Arch Ophthalmol"},{"key":"409_CR38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.STR.27.5.996","volume":"27","author":"C Sinan","year":"1996","unstructured":"Sinan C, Thierry V, Jeffrey SR, Neil AB. Neurological manifestations of acute posterior multifocal placoid pigment epitheliopathy. Stroke. 1996;27:996\u20131001.","journal-title":"Stroke"},{"key":"409_CR39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0161-6420(01)00565-6","volume":"108","author":"HS O\u2019Halloran","year":"2001","unstructured":"O\u2019Halloran HS, Berger JR, Lee WB, et al. Acute multifocal placoid pigment epitheliopathy and central nervous system involvement. Nine new cases and a review of the literature. Ophthalmology. 2001;108:861\u20138.","journal-title":"Ophthalmology"},{"key":"409_CR40","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0161-6420(85)33969-6","volume":"92","author":"AG Palestine","year":"1985","unstructured":"Palestine AG, Nussenblatt RB, Chan CC, et al. Histopathology of the subretinal fibrosis and uveitis syndrome. Ophthalmology. 1985;92:838\u201344.","journal-title":"Ophthalmology"},{"key":"409_CR41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9394(14)75749-6","volume":"113","author":"P LeHoang","year":"1992","unstructured":"LeHoang P, Ozdemir N, Benhamou A, et al. HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol. 1992;113:33.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"409_CR42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.survophthal.2011.05.003","volume":"56","author":"K Durrani","year":"2011","unstructured":"Durrani K, Zakka FR, Ahmed M, Memon M, Siddique SS, Foster CS. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol. 2011;56(6):474\u2013510.","journal-title":"Surv Ophthalmol"},{"key":"409_CR43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492.","journal-title":"Am J Ophthalmol"},{"key":"409_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000336183","volume":"51","author":"E Miserocchi","year":"2012","unstructured":"Miserocchi E, Modorati G, Foster CS. New treatments in noninfectious uveitis. Dev Ophthalmol Basel, Karger. 2012;51:1\u20136.","journal-title":"Dev Ophthalmol. Basel, Karger"},{"key":"409_CR45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/rheumatology\/ker107","volume":"50","author":"A Heiligenhaus","year":"2011","unstructured":"Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology. 2011;50:1390\u20134.","journal-title":"Rheumatology"},{"key":"409_CR46","first-page":"177","volume-title":"Diagnosis and treatment of uveitis","author":"CS Foster","year":"2002","unstructured":"Foster CS, Vitale AT. Immunosuppressive chemotherapy. In: Foster CS, Vitale AT, editors. Diagnosis and treatment of uveitis. 1st ed. Philadelphia, PA: WB Saunders; 2002. p. 177\u2013214.","edition":"1"},{"key":"409_CR47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","volume":"148","author":"S Pasadhika","year":"2009","unstructured":"Pasadhika S, Kempen JH, Newcomb CW, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009;148:500\u20139.","journal-title":"Am J Ophthalmol"},{"key":"409_CR48","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ophtha.2007.12.011","volume":"115","author":"L Sobrin","year":"2008","unstructured":"Sobrin L, Christen W, Foster CS. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology. 2008;115:1416\u201321.","journal-title":"Ophthalmology"},{"key":"409_CR49","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0002-9343(78)90533-8","volume":"64","author":"AS Fauc","year":"1978","unstructured":"Fauc AS, Doppman JL, Wolff SM. Cyclophosphamide-induced remissions in advanced polyarteritis nodosa. Am J Med. 1978;64:890\u20134.","journal-title":"Am J Med"},{"key":"409_CR50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.1780110205","volume":"11","author":"WM Fosdick","year":"1968","unstructured":"Fosdick WM, Parsons JL, Hill DF. Long-term cyclophosphamide therapy in rheumatoid arthritis. Arthritis Rheum. 1968;11:151\u201361.","journal-title":"Arthritis Rheum"},{"key":"409_CR51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.56.8.481","volume":"56","author":"I Martin-Suarez","year":"1997","unstructured":"Martin-Suarez I, D\u2019Cruz D, Mansoor M, et al. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann Rhem Dis. 1997;56:481\u20137.","journal-title":"Ann Rhem Dis."},{"key":"409_CR52","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","volume":"117","author":"RO Kacmaz","year":"2010","unstructured":"Kacmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117:576\u201384.","journal-title":"Ophthalmology"},{"key":"409_CR53","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archopht.123.5.634","volume":"123","author":"CC Murphy","year":"2005","unstructured":"Murphy CC, Greiner K, Plskova J, et al. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. Arch Ophthalmol. 2005;123:634\u201341.","journal-title":"Arch Ophthalmol"},{"key":"409_CR54","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","volume":"52","author":"J Braun","year":"2005","unstructured":"Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum. 2005;52:2447.","journal-title":"Arthritis Rheum"},{"key":"409_CR55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archopht.123.7.903","volume":"123","author":"EB Suhler","year":"2005","unstructured":"Suhler EB, Smith JR, Wertheim MS, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol. 2005;123:903.","journal-title":"Arch Ophthalmol"},{"key":"409_CR56","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1136\/bmj.b2480","volume":"339","author":"JH Kempen","year":"2009","unstructured":"Kempen JH, Daniel E, Dunn JP, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ. 2009;339:2480.","journal-title":"BMJ"},{"key":"409_CR57","first-page":"592","volume":"13","author":"AA Okada","year":"2012","unstructured":"Okada AA, Goto H, Ohno S, Mochizuki M. Multicenter study of infliximab for refractory uveoretinitis in Behcet disease. Arch Ophthalmol. 2012;13:592\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"409_CR58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2011.07.001","volume":"11","author":"E Miserocchi","year":"2011","unstructured":"Miserocchi E, Pontikaki I, Modorati G, Gattinara M, Meroni PL, Gerloni V. Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases. Autoimmun Rev. 2011;11(1):35\u20139.","journal-title":"Autoimmun Rev"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-013-0409-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-013-0409-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-013-0409-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:42:33Z","timestamp":1559432553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-013-0409-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,15]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s11882-013-0409-1","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,15]]},"article-number":"409"}}